MONTREAL, CANADA--(Marketwire - Jan. 31, 2008) - Not for distribution to U.S. news wire services or dissemination in the United States.
Theratechnologies (TSX:TH) today announced that it has entered into an underwriting agreement with BMO Capital Markets, under which the underwriter has agreed to buy 3,500,000 common shares from Theratechnologies and sell them to the public at a price of $8.50 per share, representing an aggregate issue amount of $29,750,000. The Company has also granted to the underwriter an over-allotment option to purchase an additional 350,000 common shares ($2,975,000) at the same price, exercisable by the underwriter for a period of 30 days from closing. If the over-allotment option is exercised in full, the gross proceeds to the Company will total $32,725,000. Under the terms of the underwriting agreement, the underwriter has the right to syndicate this offering. Closing is expected to occur on or about February 13, 2008 and is subject to customary closing conditions.
